Stock 4BB 4BASEBIO PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights 4basebio PLC

Equities

4BB

GB00BMCLYF79

Market Closed - London S.E.
Other stock markets
 11:35:21 2024-04-30 am EDT 		5-day change 1st Jan Change
1,070 GBX -.--% Intraday chart for 4basebio PLC +2.39% +57.35%
Apr. 10 4basebio to supply synthetic DNA for mRNA vaccine program AN
Apr. 10 4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
4basebio to supply synthetic DNA for mRNA vaccine program
AN
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program
CI
4basebio updates markets on "key milestone" with client
AN
Alpha Real Trust says in "robust" financial shape
AN
4basebio wins DNA supply contract to support RNA therapies
AN
4basebio Wins Synthetic DNA Supply Tender from CPI
MT
4basebio interim loss widens as research costs increase
AN
4basebio PLC Reports Earnings Results for the Half Year Ended June 30, 2023
CI
4basebio PLC Receives A Grant from the Bill & Melinda Gates Foundation to Advance the Development Program of Thermostable Nucleic Acid Based Vaccines
CI
4basebio PLC and Neomatrix Announce Product Supply Agreement
CI
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2022
CI
4basebio PLC Announces Further Expansion of Its UK Facilities
CI
4basebio PLC Reports Earnings Results for the Half Year Ended June 30, 2022
CI
4basebio Teams Up With Universities to Research Neurofibromatosis Treatment
MT
4basebio PLC Announces Collaboration with University of Alabama and Teesside University
CI
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2021
CI
4basebio PLC Announces Joint Development Agreement with Heqet Therapeutics
CI
4basebio PLC Announces the Expansion of its Synthetic DNA Product Offering
CI
4basebio Completes First Phase Of Synthetic DNA Business Development
MT
4basebio Unit Partners With eTheRNA To Study Linear DNA For mRNA Production
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4BB Stock
  4. News 4basebio PLC
  5. Highlights